LCN2 and metabolic dysfunction-associated steatotic liver disease: Regarding Nonalcoholic Fatty Liver Disease (NAFLD), Milner et al. observe no association between LCN2 and steatosis, lobular inflammation, ballooning or fibrosis even though the expression of LCN2 is significantly elevated in NAFLD samples compared to controls [43].